ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 906,40
0,66%
Dow Jones
44 556,04
0,30%
DAX
21 505,70
0,47%
Brent Oil
75,695
-0,32%
Bitcoin
97 921,08
0,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Cassava Sciences Inc (SAVA) Cours

Cassava Sciences Inc

Cassava Sciences Inc (SAVA)

NASDAQ
2,39
0,03
(1,27%)
Fermé 05 Février 10:00PM
Retardé de 15 minutes
2,39
0,00
(0,00%)
Après les heures de négociation: 1:47AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
2,39
Prix Achat
2,39
Prix Vente
2,40
Volume échangé
1 093 687
2,34 Fourchette du Jour 2,45
2,23 Plage de 52 semaines 42,20
Cap du marché
114,984M
Clôture Veille
2,36
Ouverture
2,38
Dernière Transaction
25
@
2.3901
Dernière heure de transaction
Volume financier
US$ 2 612 274
VWAP
2,3885
Volume moyen (3 m)
6 177 925
Actions en circulation
48 110 475
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,01
Bénéfice par action (BPA)
-2,02
Chiffre d'affairess
-
Bénéfice net
-97,22M

À propos de Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnosti... Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.cassavasciences.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Cassava Sciences Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker SAVA. Le dernier cours de clôture d'Cassava Sciences était de US$2,36. Au cours de la dernière année, les actions de Cassava Sciences ont été négociées dans une fourchette de prix de US$ 2,23 à US$ 42,20.

Cassava Sciences compte actuellement 48 110 475 actions en circulation. La capitalisation boursière d'Cassava Sciences est de US$113,54 million. Cassava Sciences a un ratio cours/bénéfice (ratio PE) de -0.01.

SAVA Dernières nouvelles

Plus de nouvelles

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA PR Newswire NEW YORK, Feb. 3, 2025 NEW YORK, Feb. 3, 2025...

03 Février 2025
PR Newswire (US)

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025 /PRNewswire/...

30 Janvier 2025
PR Newswire (US)

Class Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 27, 2025 NEW YORK, Jan. 27, 2025 /PRNewswire/...

27 Janvier 2025
PR Newswire (US)

The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 - SAVA

The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 - SAVA PR Newswire NEW YORK, Jan. 23, 2025 NEW...

23 Janvier 2025
PR Newswire (US)

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Jan. 20, 2025 NEW YORK, Jan. 20, 2025...

20 Janvier 2025
PR Newswire (US)

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan. 16, 2025 /PRNewswire/...

16 Janvier 2025
PR Newswire (US)

Contact The Gross Law Firm by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc.(SAVA)

Contact The Gross Law Firm by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc.(SAVA) PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025 /PRNewswire/ -- The...

13 Janvier 2025
PR Newswire (US)

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA PR Newswire NEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025...

09 Janvier 2025
PR Newswire (US)

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA PR Newswire NEW YORK, Jan. 6, 2025...

06 Janvier 2025
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.06-2.448979591842.452.482.280811737762.35631324CS
4-0.6-20.06688963212.993.182.280818066172.66447933CS
12-24.5-91.111937523226.8933.982.2361779255.66634006CS
26-23.61-90.80769230772642.22.23392692012.66093641CS
52-21.14-89.842753931223.5342.22.23271200913.94099096CS
156-43.16-94.753018660845.5562.492.23190861521.86170965CS
260-6.56-73.29608938558.95146.161.11303210333.42265633CS

SAVA - Frequently Asked Questions (FAQ)

What is the current Cassava Sciences share price?
The current share price of Cassava Sciences is US$ 2,39
How many Cassava Sciences shares are in issue?
Cassava Sciences has 48 110 475 shares in issue
What is the market cap of Cassava Sciences?
The market capitalisation of Cassava Sciences is USD 113,54M
What is the 1 year trading range for Cassava Sciences share price?
Cassava Sciences has traded in the range of US$ 2,23 to US$ 42,20 during the past year
What is the PE ratio of Cassava Sciences?
The price to earnings ratio of Cassava Sciences is -0,01
What is the reporting currency for Cassava Sciences?
Cassava Sciences reports financial results in USD
What is the latest annual profit for Cassava Sciences?
The latest annual profit of Cassava Sciences is USD -97,22M
What is the registered address of Cassava Sciences?
The registered address for Cassava Sciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Cassava Sciences website address?
The website address for Cassava Sciences is www.cassavasciences.com
Which industry sector does Cassava Sciences operate in?
Cassava Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CAPTCaptiVision Inc
US$ 1,024
(133,26%)
246M
QNTMQuantum Biopharma Ltd
US$ 6,70
(110,69%)
78,56M
LTRYLottery com Inc
US$ 0,58
(85,90%)
129,21M
CPIXCumberland Pharmaceutical Inc
US$ 3,7801
(77,47%)
18,49M
INKTMiNK Therapeutics Inc
US$ 12,08
(53,69%)
350,86k
OMGAOmega Therapeutics Inc
US$ 0,1473
(-69,25%)
11,71M
VIRXViracta Therapeutics Inc
US$ 0,0352
(-54,76%)
6,33M
CYNCYNGN Inc
US$ 0,0708
(-39,44%)
137,42M
UPCUniverse Pharmaceuticals Inc
US$ 0,2663
(-36,20%)
1,9M
CSAICloudastructure Inc
US$ 12,98
(-31,68%)
57,03k
NVDANVIDIA Corporation
US$ 118,65
(1,71%)
256,77M
CAPTCaptiVision Inc
US$ 1,024
(133,26%)
246M
PLTRPalantir Technologies Inc
US$ 103,83
(23,99%)
230,5M
RGTIRigetti Computing Inc
US$ 13,71
(1,78%)
159,64M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1518
(-22,11%)
142,77M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SAVA
Cassava Sciences
BOV
L1CA34Q
Laboratory Corp of America
LSE
TC28
Morg.st.b.v 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces